EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A review of bismuth‐based nanoparticles and their applications in radiosensitising and dose enhancement for cancer radiation therapy

Daryoush Shahbazi-Gahrouei iD, Yazdan Choghazardi iD, Arezoo Kazemzadeh iD, Paria Naseri iD, Saghar Shahbazi-Gahrouei

IET Nanobiotechnology · 2023-06 · 17 (4) · 302-311

DOI: 10.1049/nbt2.12134 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift IET Nanobiotechnology, online erschienen am 04.05.2023. Verfasst von Daryoush Shahbazi-Gahrouei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. Hauptthemen laut MEDLINE: Nanoparticles, Radiation-Sensitizing Agents, Neoplasms. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

About 50% of cancer patients receive radiation therapy. Despite the therapeutic benefits of this method, the toxicity of radiation in the normal tissues is unavoidable To improve the quality of radiation therapy, in addition to other methods such as IMRT, IGRT, and high radiation dose, nanoparticles have shown excellent potential when ionising radiation is applied to the target volume. Recently, bismuth‐based nanoparticles (BiNPs) have become particularly popular in radiation therapy due to their high atomic numbers (Z), high X‐ray attenuation coefficient, low toxicity, and low cost. Moreover, it is easy to synthesise in a variety of sizes and shapes. This study aimed to review the effects of the bismuth‐based NP and its combination with other compounds, and their potential synergies in radiotherapy, discussed based on their physical, chemical, and biological interactions. Targeted and non‐targeted bismuth‐based NPs used in radiotherapy as radiosensitizers and dose enhancement effects are described. The results reported in the literature were categorised into various groups. Also, this review has highlighted the importance of bismuth‐based NPs in different forms of cancer treatment to find the highest efficiency for applying them as a suitable candidate for various cancer therapy and future clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesRadiation-Sensitizing AgentsNeoplasmsHumansBismuth

Stichwörter der Autor:innen

nanomedicinenanoparticlesradiation therapy

Substanzen

BismuthRadiation-Sensitizing Agents

Autor:innen und Institutionen

  • Department of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

ORCID-Profile: Daryoush Shahbazi-Gahrouei, Yazdan Choghazardi, Arezoo Kazemzadeh, Paria Naseri

Zitieren

APA

Shahbazi-Gahrouei, D., Choghazardi, Y., Kazemzadeh, A., Naseri, P., & Shahbazi-Gahrouei, S. (2023). A review of bismuth‐based nanoparticles and their applications in radiosensitising and dose enhancement for cancer radiation therapy. IET Nanobiotechnology, 17(4), 302-311. https://doi.org/10.1049/nbt2.12134

Vancouver

Shahbazi-Gahrouei D, Choghazardi Y, Kazemzadeh A, Naseri P, Shahbazi-Gahrouei S. A review of bismuth‐based nanoparticles and their applications in radiosensitising and dose enhancement for cancer radiation therapy. IET Nanobiotechnology. 2023;17(4):302-311. doi:10.1049/nbt2.12134

BibTeX
@article{ShahbaziGahrouei2023,
  author = {Shahbazi-Gahrouei, Daryoush and Choghazardi, Yazdan and Kazemzadeh, Arezoo and Naseri, Paria and Shahbazi-Gahrouei, Saghar},
  title = {A review of bismuth‐based nanoparticles and their applications in radiosensitising and dose enhancement for cancer radiation therapy},
  journal = {IET Nanobiotechnology},
  year = {2023},
  volume = {17},
  number = {4},
  pages = {302--311},
  doi = {10.1049/nbt2.12134}
}
Kostenlos starten →